The Australian CRO
for International
Biotechs

An agile solutions-focussed culture
Maximizing value, speed, and data quality

Globally accepted data

Avance Clinical has a world-class reputation for quality data that is accepted by all regulatory authorities including FDA. In-house Medidata trained specialists.

Rapid start-up

Avance Clinical can deliver Site Initiation Visit (SIV) and Study Start in 5 – 6 weeks. No IND required.

Extend budget by 43.5%

Avance Clinical can secure the maximum rebate on your clinical trial spend with the Australian Government clinical trial rebate program.

Industry-leading technology

Avance Clinical invests heavily in the industry-leading technology platforms to support speed, communications, and regulatory compliance.

An Experienced Team

Learn more about us here

Recent features and awards

Talk to our Team   CONTACT US

Established & Proven over 24 years

Agile and solutions-focussed

Avance Clinical is the largest full-service Australian CRO delivering quality clinical trials with globally accepted data in Australia and New Zealand for international biotechs.

Frost & Sullivan awards

Avance Clinical, a Frost & Sullivan Asia-Pacific CRO Best Practices Award recipient for the past two years, has been providing CRO services in the region for the past 24 years.

The company’s clients are biotechs in their early phases of drug development that need fast, agile, and adaptive solution-oriented clinical research services.

Pre-clinical through to Phase 1 and 2

Avance Clinical offers pre-clinical services with their experienced ClinicReady team right through to Phases 1 and 2 leveraging significant Government incentive rebates of 43.5% and rapid start-up regulatory processes.

With experience across more than 105 indications, the CRO can deliver world-class results and high-quality internationally accepted data for FDA and EMA review.

Avance Clinical delivers customised solutions designed around specific client needs rather than a one size fits all approach.

Technology

As a company, Avance Clinical has focused on state-of-the-art technology and systems across all functional areas to provide clients with the most effective processes. Medidata, Oracle, and Medrio are just some of the technology partners.

Experienced Team

More than 150 In-House CRO Specialists

Avance Clinical had its genesis in the University of South Australia in the early 1980s as the Centre for Pharmaceutical Research, when a group of academic scientists began providing clinical research and bioanalytical services to the local pharmaceutical industry.

Since then, it has grown to become the leading mid-sized CRO servicing the international drug development industry.

Avance Clinical offers some of the most extensive in-house clinical services including:

  • ClinicReady – pre-clinical services
  • Clinical Monitoring Management
  • Data Management
  • eClinical Solutions
  • Safety and Pharmacovigilance
  • Medical Writing
  • Project Management
  • Statistics and Pharmacokinetics
  • Quality Assurance

Pre-clinical ClinicReady

The ClinicReady range of services constitutes a natural progression in Avance Clinical’s role as the premier provider of early drug development support to the biotechnology sector. The company recognises the major challenges faced by small biotechnology companies, particularly start-up companies who seek to drive their novel therapeutics to demonstration of safety and preliminary clinical Proof of Concept.

 

Discover More

Medical Writing

The Avance Clinical biostatistics and pharmacokinetics experts provide specialist guidance for your clinical research trial design and analysis.

Discover More

Data Management

Avance Clinical’s data management team has gained a world-class reputation for accuracy, precision, and quality of their biostatistics and pharmacokinetic (PK) analysis.

Discover More

Safety and Pharmacovigilance

Clinical trials safety monitoring and reporting is vital to ensure participant safety, data integrity, and regulatory compliance.

Regulatory guidelines around clinical trial safety monitoring and reporting demand strict safety management procedures, from a highly-skilled, and experienced safety team.

Discover More

eClinical Solutions

The Avance Clinical team works with eClinical leaders such as Medrio, Medidata, and Oracle to offer regulatory compliant and patient-centric tools for rapid start-up and continual data flow.

Discover More

Quality Assurance

Data quality is at the heart of everything at Avance Clinical. Delivered by our highly experienced staff we support our clients with their clinical trial audit to achieve their quality objectives for their clinical research trials.

Discover More

Clinical Monitoring Management

Avance Clinical has experienced clinical monitoring staff across all phases of clinical trials and can collaboratively support the Australian CRO arm of multinational trials.

Discover More

Project Management

Avance Clinical provides each clinical research trial with a dedicated Project Manager to ensure that milestones are reached, timelines are met and that our clients receive effective communication and ongoing status reports.

Discover More

“It has been a great pleasure working with you on this project. Your flexibility, pragmatic approaches and focus on the work has been exceptional. I am looking forward to have the next compound entering the clinic with you.”

Head of Drug Discovery, Pharmaxis Ltd

“Working with the Avance Team has helped us to develop and complete high quality and compliant clinical studies. I especially appreciate their penchant for communication, quality and pragmatism.”

Sr. Vice President, Regulatory, Quality & Clinical Affairs, Atossa Genetics, Inc.

“Having conducted several Phase I studies in Australia it made sense to continue in the country with our Phase II program, particularly given the high-quality support we have received from our CRO.”

Atossa Therapeutics Inc.

“Avance Clinical has proven themselves to be my “Champions”, anticipating problems and always acting in the interest of getting the trial done professionally, resourcefully, and in alignment with the goals of the Sponsor and well-being of the volunteers.”

Chairman of the Board and Chief Medical Officer, BioFactura Inc

“Medrio has supported numerous study starts in Australia, over 150 with Avance Clinical alone, and we’re always impressed with the speed of their timelines.”

CEO Mike Novotny (former), Medrio

“We reached out to Avance to refine and polish a substantive and comprehensive drug study clinical trial ethics application. The Avance Team were remarkably quick to respond to our enquiry. Avance provided us within a very short turn-around period a comprehensive appraisal of the documentation covering all elements including protocol, ethics, investigator brochure and patient information and consent. Avance were highly engaged with the research investigator team and suggested changes were clear and well rationalised. The services provided were cost-effective and well justified. I have no hesitation to recommend Avance as a quality CRO”.

Curtin Health Innovation Research Institute
195
Studies in the past 5 years
150
Experienced Team Members
10,000
Participants past 5 years
24
Years of of CRO experience

“Avance Clinical’s clients are international biotech companies primarily from the United States, United Kingdom, Japan, China, South Korea, Taiwan, France, and Germany. These clients are seeking a premium CRO with the same experience and advanced technology platforms offered by the major global CROs, but with an agile and customer focused approach to clinical management in Australia and New Zealand.”

Supriya Lala KunduBest Practices Research Analyst, Frost & Sullivan

Latest News

View our latest client and company

August 10, 2021 in Company Awards, Company News

Avance Clinical Awarded Frost & Sullivan 2021 Asia-Pacific CRO Best Practices Award for Customer Value Leadership

Avance Clinical, the largest premium Australian CRO for international biotechs, has been awarded the prestigious Frost & Sullivan 2021 Asia-Pacific CRO Customer Value Leadership Award, the second consecutive Asia-Pacific (APAC)…
Read More
July 9, 2021 in Client News, Company News

Avance Clinical Congratulates Client Tetherex Pharmaceuticals on Initiation of Dosing in a Phase 1 Clinical Study Using a Novel Single-Cycle Adenovirus Vaccine Strategy in Australia

The largest Australian full-service CRO for international biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner Avance Clinical today congratulated client Tetherex Pharmaceuticals on first patient dosing for…
Read More
July 9, 2021 in Client News

Avance Clinical Client XWPharma Announces Positive Results from Phase 1 Clinical Trials of XW10172, in Development as Once-Nightly Therapy for Sleep Disorders in Patients with Neurodegenerative Diseases

The leading Australian CRO for international biotechs and Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award winner Avance Clinical today congratulated client XWPharma on receiving positive results from its Phase 1…
Read More
View All News

Ready To Partner with Us?

Contact Us